ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 85 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $20,249,000 | -0.5% | 1,011,431 | +28.4% | 2.52% | +10.5% |
| Q2 2018 | $20,347,000 | -10.1% | 787,723 | -16.8% | 2.28% | -26.3% |
| Q1 2018 | $22,633,000 | -47.4% | 947,006 | -25.4% | 3.09% | -45.1% |
| Q4 2017 | $43,044,000 | +19.5% | 1,270,123 | -25.4% | 5.64% | +31.0% |
| Q3 2017 | $36,020,000 | +45.0% | 1,701,477 | +19.8% | 4.30% | +48.9% |
| Q2 2017 | $24,839,000 | +19.1% | 1,420,156 | +19.2% | 2.89% | +37.4% |
| Q1 2017 | $20,847,000 | +1.0% | 1,191,282 | -2.5% | 2.10% | -7.7% |
| Q4 2016 | $20,643,000 | +7.6% | 1,221,463 | +4.5% | 2.28% | +32.9% |
| Q3 2016 | $19,188,000 | +24.6% | 1,169,275 | +15.0% | 1.72% | +28.0% |
| Q2 2016 | $15,397,000 | +96.0% | 1,017,000 | +87.2% | 1.34% | +116.8% |
| Q1 2016 | $7,855,000 | – | 543,238 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,601,351 | $43,963,000 | 9.03% |
| Granite Point Capital Management, L.P. | 256,031 | $4,327,000 | 3.45% |
| Opaleye Management Inc. | 285,000 | $4,817,000 | 2.84% |
| Brenner West Capital Advisors | 1,221,463 | $20,643,000 | 2.28% |
| ARMISTICE CAPITAL, LLC | 536,000 | $9,058,000 | 2.14% |
| NEXTHERA CAPITAL LP | 151,670 | $2,563,000 | 1.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 185,234 | $3,130,000 | 1.41% |
| Cheyne Capital Management (UK) LLP | 144,765 | $2,448,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 270,000 | $4,563,000 | 1.16% |
| Mosaic Family Wealth, LLC | 123,314 | $2,084,000 | 0.96% |